Paik Kwang Ind (001340) - Net Assets
Based on the latest financial reports, Paik Kwang Ind (001340) has net assets worth ₩218.61 Billion KRW (≈ $148.15 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩601.10 Billion ≈ $407.35 Million USD) and total liabilities (₩382.49 Billion ≈ $259.21 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 001340 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩218.61 Billion |
| % of Total Assets | 36.37% |
| Annual Growth Rate | 5.95% |
| 5-Year Change | 20.42% |
| 10-Year Change | 4.33% |
| Growth Volatility | 33.51 |
Paik Kwang Ind - Net Assets Trend (2008–2024)
This chart illustrates how Paik Kwang Ind's net assets have evolved over time, based on quarterly financial data. Also explore 001340 asset base for the complete picture of this company's asset base.
Annual Net Assets for Paik Kwang Ind (2008–2024)
The table below shows the annual net assets of Paik Kwang Ind from 2008 to 2024. For live valuation and market cap data, see Paik Kwang Ind (001340) market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ₩213.43 Billion ≈ $144.64 Million |
-0.10% |
| 2023-12-31 | ₩213.65 Billion ≈ $144.79 Million |
+2.07% |
| 2022-12-31 | ₩209.32 Billion ≈ $141.85 Million |
+10.44% |
| 2021-12-31 | ₩189.54 Billion ≈ $128.45 Million |
+6.94% |
| 2020-12-31 | ₩177.23 Billion ≈ $120.11 Million |
+5.91% |
| 2019-12-31 | ₩167.35 Billion ≈ $113.41 Million |
+8.72% |
| 2018-12-31 | ₩153.92 Billion ≈ $104.31 Million |
+18.21% |
| 2017-12-31 | ₩130.21 Billion ≈ $88.24 Million |
+8.07% |
| 2016-12-31 | ₩120.49 Billion ≈ $81.66 Million |
-41.10% |
| 2011-12-31 | ₩204.57 Billion ≈ $138.64 Million |
+2.35% |
| 2010-12-31 | ₩199.88 Billion ≈ $135.46 Million |
+10.83% |
| 2009-12-31 | ₩180.35 Billion ≈ $122.22 Million |
+112.91% |
| 2008-12-31 | ₩84.71 Billion ≈ $57.41 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Paik Kwang Ind's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 130.8% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ₩62.40 Billion | 29.24% |
| Other Components | ₩151.03 Billion | 70.76% |
| Total Equity | ₩213.43 Billion | 100.00% |
Paik Kwang Ind Competitors by Market Cap
The table below lists competitors of Paik Kwang Ind ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Jin Air Co Ltd
KO:272450
|
$219.32 Million |
|
TriSalus Life Sciences Inc.
NASDAQ:TLSI
|
$219.34 Million |
|
Yungjin Pharm Co Ltd
KO:003520
|
$219.38 Million |
|
Grupo Industrial Saltillo S.A.B. de C.V
MX:GISSAA
|
$219.39 Million |
|
StealthGas Inc
F:S6W
|
$219.25 Million |
|
Meteoric Resources NL
F:RNF
|
$219.20 Million |
|
Iron Force Industrial Co Ltd
TW:2228
|
$219.18 Million |
|
PETROTAL CORP.
F:SER1
|
$219.12 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Paik Kwang Ind's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 213,651,817,620 to 213,430,158,020, a change of -221,659,600 (-0.1%).
- Net income of 3,600,645,960 contributed positively to equity growth.
- Dividend payments of 2,648,946,420 reduced retained earnings.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩3.60 Billion | +1.69% |
| Dividends Paid | ₩2.65 Billion | -1.24% |
| Other Changes | ₩-1.17 Billion | -0.55% |
| Total Change | ₩- | -0.10% |
Book Value vs Market Value Analysis
This analysis compares Paik Kwang Ind's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.52x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 2.36x to 1.52x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | ₩3107.11 | ₩7330.00 | x |
| 2018-12-31 | ₩3582.89 | ₩7330.00 | x |
| 2019-12-31 | ₩3895.44 | ₩7330.00 | x |
| 2020-12-31 | ₩4014.38 | ₩7330.00 | x |
| 2021-12-31 | ₩4293.11 | ₩7330.00 | x |
| 2022-12-31 | ₩4741.20 | ₩7330.00 | x |
| 2023-12-31 | ₩4839.32 | ₩7330.00 | x |
| 2024-12-31 | ₩4834.30 | ₩7330.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Paik Kwang Ind utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 1.69%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 1.47%
- • Asset Turnover: 0.53x
- • Equity Multiplier: 2.18x
- Recent ROE (1.69%) is below the historical average (7.20%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2008 | 10.32% | 3.79% | 1.03x | 2.64x | ₩273.95 Million |
| 2009 | 8.43% | 4.74% | 0.92x | 1.94x | ₩-2.78 Billion |
| 2010 | 10.80% | 6.03% | 0.97x | 1.85x | ₩1.59 Billion |
| 2011 | 3.88% | 2.05% | 0.91x | 2.08x | ₩-12.44 Billion |
| 2016 | 1.97% | 1.76% | 0.48x | 2.33x | ₩-9.68 Billion |
| 2017 | 4.87% | 4.37% | 0.52x | 2.15x | ₩-6.68 Billion |
| 2018 | 14.50% | 12.72% | 0.59x | 1.93x | ₩6.93 Billion |
| 2019 | 9.58% | 9.52% | 0.51x | 1.97x | ₩-706.00 Million |
| 2020 | 5.72% | 5.92% | 0.53x | 1.82x | ₩-7.58 Billion |
| 2021 | 7.86% | 7.79% | 0.53x | 1.90x | ₩-4.06 Billion |
| 2022 | 10.35% | 9.31% | 0.58x | 1.93x | ₩739.87 Million |
| 2023 | 3.62% | 3.31% | 0.55x | 2.00x | ₩-13.64 Billion |
| 2024 | 1.69% | 1.47% | 0.53x | 2.18x | ₩-17.74 Billion |
Industry Comparison
This section compares Paik Kwang Ind's net assets metrics with peer companies in the Specialty Chemicals industry.
Industry Context
- Industry: Specialty Chemicals
- Average net assets among peers: $1,306,062,725,001
- Average return on equity (ROE) among peers: 5.34%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Paik Kwang Ind (001340) | ₩218.61 Billion | 10.32% | 1.75x | $219.31 Million |
| DL Holdings CO. LTD. (000210) | $4.75 Trillion | 1.28% | 1.56x | $1.01 Billion |
| DL Holdings Co Ltd Preferred (000215) | $5.15 Trillion | 5.16% | 1.41x | $34.58 Million |
| Norooholdings (000320) | $272.56 Billion | 3.14% | 1.23x | $153.49 Million |
| Noroo Holdings Co Ltd (000325) | $583.54 Billion | 0.27% | 0.81x | $5.20 Million |
| Samhwa Paint (000390) | $120.78 Billion | 8.80% | 1.21x | $158.92 Million |
| Kangnam Jevisco Co Ltd (000860) | $484.92 Billion | 4.78% | 0.21x | $148.36 Million |
| Bo Lak (002760) | $43.76 Billion | 2.53% | 0.22x | $46.56 Million |
| Songwon Industrial (004430) | $202.35 Billion | 10.96% | 2.28x | $257.79 Million |
| Cho Kwang Pain (004910) | $150.26 Billion | 11.15% | 0.61x | $33.78 Million |
About Paik Kwang Ind
Paikkwang Industrial Co.,Ltd produces and sells inorganic chemical products in South Korea and internationally. It offers caustic soda, hydrochloric acid, liquid chlorine, sodium hypochlorite, and nitrous oxide, as well as nitrogen trifluoride and hydrogen. It also provides D-sorbitol, maltitol syrup, and polyglycitol syrup, as well as re-inspection and internal treatment of high pressure gas cyl… Read more